// App-Quantinova.ai

e14081 : A phase I study of NC-6004, a micellar formulation of cisplatin, in combination with gemcitabine in Japanese patients with advanced solid tumors.

Researchers

Presenter

  • Tetsuya Hamaguchi

Principal Investigators

  • Toshihiko Doi

  • Kohei Shitara

  • Satoru Iwasa

  • Yasuhiro Shimada

  • Mitsunori Harda

  • Kenichiro Naito

  • Naoto Hayashi

  • Atsuhiro Masada

  • Atsushi Ohtsu

Medical Centers

  • National Cancer Center Hospital, Tokyo, Japan

  • National Cancer Center Hospital, Tokyo, Japan

  • National Cancer Center, EPOC, Chiba, Japan

  • Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan

  • Division of Clinical Oncology, Kochi Health Sciences Center, Kochi, Japan

  • NANOCARRIER CO., LTD., Tokyo, Japan

Locations

  • Japan

Companies

  • NanoCarrier Co., Ltd

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Nephrotoxicity

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Cisplatin

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Pharmacodynamics

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved